1. Home
  2. POWW vs AVXL Comparison

POWW vs AVXL Comparison

Compare POWW & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMMO Inc.

POWW

AMMO Inc.

HOLD

Current Price

$2.24

Market Cap

235.8M

Sector

Industrials

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.40

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWW
AVXL
Founded
1990
2004
Country
United States
United States
Employees
81
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.8M
237.2M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
POWW
AVXL
Price
$2.24
$2.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$2.40
$22.00
AVG Volume (30 Days)
1.3M
1.3M
Earning Date
02-09-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.56
N/A
Revenue Next Year
$0.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$2.30
52 Week High
$2.60
$13.99

Technical Indicators

Market Signals
Indicator
POWW
AVXL
Relative Strength Index (RSI) 47.83 40.79
Support Level $1.94 N/A
Resistance Level $2.46 $2.80
Average True Range (ATR) 0.12 0.15
MACD -0.02 -0.02
Stochastic Oscillator 10.13 24.30

Price Performance

Historical Comparison
POWW
AVXL

About POWW AMMO Inc.

Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: